Skip to main content

International Epilepsy Congress (IEC), 2025

Filter
Close
Content type:
Brivaracetam Adjunctive Therapy in Paediatric and Adult Patients With Focal-Onset Seizures in Mid-European Countries: 12-Month, Real-World Outcomes from the BRIVA-REG Study
Dimitrios Zafeiriou, Vasilios K Kimiskidis, András Fogarasi, et al.
Neonatal AAV Gene Therapy Rescues Phenotypes in STXBP1 Haploinsufficient Mice
Natalia Rodriguez, Yana van den Herrewegen, Jérôme Clasadonte, et al.
In vitro electrophysiological study of hippocampal network activity in a mouse model of STXBP1 haploinsufficiency
Isabelle Niespodziany, Natalia Rodriguez, Christian Wolff
Rescue of neuronal activity in iPSC-derived STXBP1 in vitro disease models using viral vectors
AR Gomes, C Besse, B Danis, et al.
Expression and quantification of STXBP1 splice variants in rodent and non-human primate brain tissues
Yana van den Herrewegen, Mariya Semkova, Marcella Widya, et al.
Characterising Patient and Caregiver Experiences Resulting From Prolonged Seizures
Danya Kaye, Catherine Cooles, Cheryl Hudson, et al.
Describing the Population of Patients With Prolonged Seizures: Results From a Global Real-World Point-in-Time Study
Eugen Trinka, Matthew C Walker, Reetta Kälviäinen, et al.
Understanding and Optimising the Seizure Emergency Pathway
Noem Sain, Milena Blyth, Beth Clark, et al.
Global Seizure Rescue Medication Landscape: Availability & Reimbursement
Patricia Shafer, Noem Sain, Cédric Laloyaux, et al.
Seizure Duration and Time-point Cutoffs for Statistically Defining a Prolonged Seizure: A Post-Hoc Analysis of the SCORE Video-EEG Database
Bersabeh Sile, Pirgit Meritam Larsen, Anna Kuba, et al.
Prospective evaluation of fenfluramine use in a cohort of pediatric and adult patients with Dravet syndrome
Cathrine E. Gjerulfsen, Anne V. Jakobsen, Marina Nikanorova, et al.
Barriers to and benefits of identifying patients with developmental and epileptic encephalopathies in adult care settings
Jude Luker, Kirsty Mearns, Kay Fisher, et al.
Exposure-Response Relationships of Fenfluramine in Patients With Dravet Syndrome and Lennox-Gastaut Syndrome
Aravind Mittur, Christopher M Rubino, Brooks Boyd
Post Hoc Analysis of Fenfluramine for Lennox-Gastaut Syndrome by Baseline Frequency Quartiles of Seizures Associated With a Fall
Kelly G. Knupp, Rima Nabbout, Ingrid E. Scheffer, et al.
Impact of Fenfluramine on Convulsive Seizure Frequency in Dose-capped Patients With Dravet Syndrome
Rima Nabbout, Kelly G. Knupp, Lieven Lagae, et al.
Improving Lives in Dravet Syndrome: Overcoming Challenges in the Family Journey
Soto Insuga V, Vacas Montero E, Zumárraga Astorqui L, et al.
A Retrospective Claims Study Evaluating Mortality in Patients With Lennox-Gastaut or Dravet Syndromes in the United States
Rejena Ameen, Elaine C. Wirrell, Joseph Sullivan, et al.
A Stratified Analysis of Efficacy and Safety of Fenfluramine in Patients With Dravet Syndrome
Rima Nabbout, Joseph Sullivan, Stéphane Auvin, et al.
Use of Fenfluramine and Cannabidiol in Daily Practice: A Retrospective Analysis of German Prescription Claims
Milka Pringsheim, Felix von Podewils, Claudio Schiener, et al.
Tolerability and Safety of Fenfluramine and Global Functioning of Patients in a Combined Open-label Extension Study of Children and Adults With Dravet and Lennox-Gastaut Syndromes
An-Sofie Schoonjans, Kelly G. Knupp, Antonio Gil-Nagel, et al.
A European Study of the Effectiveness of Risk Minimisation Measures for Fenfluramine Oral Solution in Dravet Syndrome and Lennox-Gastaut Syndrome
Amélie Lothe, Madhur Goyal, Jigs Chheda, et al.
A checklist to support the diagnosis of Lennox-Gastaut syndrome
Nicola Specchio, Alexis Arzimanoglou, Stéphane Auvin, et al.
Lennox-Gastaut Syndrome. Situation analysis and Family Journey
Vacas Montero E, Zumárraga Astorqui L, Zurita Santamaría J, et al.